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A growing number of studies have shown that outcomes are likely
to be improved for certain complex surgical procedures if these are
performed either within high-volume hospitals or by high-volume
surgeons (Begg et al, 1998; Birkmeyer et al, 2002, 2003). As a
consequence, the UK National Institute of Clinical Excellence
(NICE), a government-funded body that provides healthcare
professionals and the public with guidance on ‘best practice’, has
recommended that complex urological cancer surgery be centra-
lised into centres serving a population of at least one million
(National Institute of Clinical Excellence, 2002). Based on this
population, this should result in at least 50 radical operations for
prostate and bladder cancer being performed per centre per year.
The number of clinicians involved in treating these patients in the
centres will determine whether this also provides relatively high
volume at the surgeon level. Volume-based policies such as that
advocated by NICE are not without controversy however, as high
volume can only be a proxy for other factors that improve
healthcare outcomes (Birkmeyer, 2000; Berger et al, 2003).
There exist three explanations of how volume and outcome may
be linked (Birkmeyer, 2000). The first and most intuitive is the
‘practice makes perfect’ explanation. This postulates that improve-
ments in outcome result from the enhanced performance gained
through increased practice and experience. This effect may act in a
number of areas. For example, at the individual level, a surgeon
may be able to reduce operative time and possibly blood loss. At
the structural level, a hospital may be better able to implement
evidence-based guidelines and enhance multidisciplinary team
working. The second of these explanations has been described as
the ‘selective referral’ explanation. Hospitals or surgeons who have
good outcomes may attract additional referrals and thus increase
their volume (Ihse, 2003). This is almost certainly the case in
certain centres in the USA, for example in those that attract an
international clientele. The third explanation proposes that
observed effects between volume and outcome might be explained
by ‘confounding’. In other words, a difference in case-mix
(incorporating both comorbidity and disease severity) may exist
such that high-volume hospitals or surgeons care for lower risk
patients.
Most evidence on the volume–outcome relationship originates
from studies performed in the US. The validity of this evidence
would be stronger if more data from other countries and
healthcare systems were available. The healthcare system in the
UK differs from that in the US in that most British patients
currently do not have much control over where they receive their
surgical treatment or by whom the surgical procedure is
performed, although current initiatives would be expected to
change this. If a volume–outcome relationship was to be found as
consistently in the UK as in the US, this would mitigate against the
selective referral explanation. Confounding is less likely to play a
significant role, as most studies that attempt to adjust for
confounding still demonstrate a positive effect between volume
and outcome (Birkmeyer, 2000). Furthermore, the implementation
of volume-based policies aimed at improving surgical outcomes
implies that policy makers have embraced the dominance of the
practice makes perfect explanation.
Based on available evidence, it is likely that implementing a
volume-based policy for complex urological cancer surgery will, on
average, result in improved outcomes (Nuttall et al, 2004). In
addition, there may be other desirable by-products such as more
intensive training opportunities and easier recruitment of patients
into trials. The large number of cases at high-volume centres
should also ensure greater statistical precision surrounding
reported patient outcomes.
However, by their nature, volume-based health policies need to
be applied to an entire healthcare system in order to have the
maximum desired effect. This has a number of implications. First,
low-volume providers with good outcomes will be lost to the
healthcare system if they are either unwilling or unable to practise
within high-volume centres. Second, there may also be an
incentive to increase volumes through operating on patients who
may not previously have been considered for surgery. Third, newly
created high-volume providers may not necessarily produce better
outcomes than the low-volume providers that preceded them
(Shahian and Normand, 2003). Fourth, the addition of another
layer to secondary care may put pressure on effective commu-
nication and adversely affect the continuum of care (Haggerty et al,
2003). Finally, some patients may have a preference for locally
based care regardless of the local outcomes.
While acknowledging these methodological problems, if it is
taken as given that outcomes improve with increasing volumes,
uncertainties remain in how to translate this effect into policy. For
instance, should low-volume providers be excluded from the
healthcare system or should referral only take place to those
providers with high volume? Moreover, at what level should
volume thresholds be set? These thresholds define the minimum
number of cases a provider should perform in order to be
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identify these thresholds, considerable variation in methodology
and threshold levels has been encountered (Christian et al, 2003;
Shahian and Normand, 2003). What is more, should these
thresholds be set at the surgeon level, at the hospital level or
both? Should account be taken of experience in related fields?
These questions illustrate the need for continuing research to
define the shape of the volume and outcome curve for differing
categories of providers.
Following implementation of volume-based policies, and within
the new configuration, the next challenge is to identify character-
istics of both centres and surgeons associated with good outcomes
so that these practices might be used in both selection and training
and also emulated by others to improve outcomes even further
(Begg and Scardino, 2003; Shahian and Normand, 2003). This will
continue to improve the quality of care while the answer to the
question of ‘how many is enough?’ remains so elusive.
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